Current Perspectives on HER2 Testing: A Review of National Testing Guidelines
Open Access
- 1 February 2003
- journal article
- review article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 16 (2), 173-182
- https://doi.org/10.1097/01.mp.0000052102.90815.82
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Moving Forward: Herceptin® in the Adjuvant SettingOncology, 2002
- Predicting HER2 status of breast cancer from basic pathology features: HER2 status of 1500 breast cancers determined by immunohistochemistry and flourescence In situ hybridisation with pathology correlationEuropean Journal of Cancer, 2002
- A Formalin-Fixed, Paraffin-Processed Cell Line Standard for Quality Control of Immunohistochemical Assay of HER-2/neu Expression in Breast CancerAmerican Journal of Clinical Pathology, 2002
- Her2 Testing recommendations in AustraliaPathology, 2001
- Recommendations for HER2 testing in the UKJournal of Clinical Pathology, 2000
- Sensitivity of HER-2/neu Antibodies in Archival Tissue Samples of Invasive Breast CarcinomasAmerican Journal of Clinical Pathology, 2000
- Assessment of HER2 status in breast cancer: why, when and how?European Journal of Cancer, 2000
- Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ HybridizationLaboratory Investigation, 2000
- The biology of erbB-2/nue/HER-2 and its role in cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987